secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001171843-23-005230
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

The Joint Corp. Q2 system-wide sales +13% to $120.1M; financial results postponed due to review
--------------------------------------------------------------------------------

- System-wide sales $120.1M (+13% YoY); system-wide comp sales +5%.
- Clinic count 890 at June 30; subsequent openings brought total to 900 in August 2023.
- Unrestricted cash $13.6M (Dec 2022: $9.7M); operating cash flow $8.4M including $4.8M ERC.
- Financial results postponed due to ongoing review of regional developer arrangements (non-cash impact).
- Sold 21 franchise licenses in Q2; opened 26 new clinics, closed 6.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000117184323005230/0001171843-23-005230-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000117184323005230/f8k_081023.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-005230

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer